SubsidieMeestersMosquito-specific phagostimulants and pheromones for environment-friendly mosquito vector control
Molecular Attraction aims to evaluate the efficacy and environmental impact of innovative mosquito-specific semiochemicals in sub-Saharan Africa to enhance vector control and reduce disease burden.
Projectdetails
Introduction
Each year, chemicals worth €8bn are used for Mosquito Vector Control (MVC). Still, mosquito-borne diseases constitute a major socio-economic burden. As insecticides start losing efficacy and toxic chemicals are being banned from use (in the west in particular), we are becoming increasingly defenseless. By 2050, an additional 1bn people will be at risk of contracting at least one mosquito-borne disease due to the rapid expansion of habitats of mosquito vectors.
Company Overview
Molecular Attraction is a pioneer in mosquito-specific phagostimulants and pheromones. We can control mosquito behaviour using minute quantities of highly effective, affordable, and perfectly green semiochemicals.
Project Objectives
In the project, we will conduct a large-scale trial in sub-Saharan Africa to evaluate the following:
- Efficacy
- Cost-effectiveness
- Environmental impact of our unique blends.
Market Strategy
The trial results will be leveraged to enter the global MVC market.
Financiële details & Tijdlijn
Financiële details
| Subsidiebedrag | € 2.500.000 |
| Totale projectbegroting | € 4.171.988 |
Tijdlijn
| Startdatum | 1-12-2023 |
| Einddatum | 30-11-2025 |
| Subsidiejaar | 2023 |
Partners & Locaties
Projectpartners
- MOLECULAR ATTRACTION ABpenvoerder
Land(en)
Vergelijkbare projecten binnen EIC Accelerator
| Project | Regeling | Bedrag | Jaar | Actie |
|---|---|---|---|---|
A new cardioprotective drug for acute treatment of myocardial infarctionResoTher aims to validate RTP-026, an immunomodulating therapy, to reduce heart damage and HF risk post-myocardial infarction through Phase II clinical studies. | EIC Accelerator | € 2.499.999 | 2024 | Details |
Clear, scalable and scientific framework to measure terrestrial biodiversity3Bee leverages IoT, wildlife monitoring, and satellite data to measure and regenerate biodiversity, generating certified Biodiversity Credits for corporations to enhance ESG reporting and brand value. | EIC Accelerator | € 2.252.714 | 2024 | Details |
Novel and Scalable microbial products for REgenerative agricultureN-Spire aims to revolutionize agriculture by creating a sustainable bioactive fertilizer through innovative manufacturing techniques, enhancing soil health and reducing chemical dependency. | EIC Accelerator | € 2.499.999 | 2024 | Details |
Quantum-based Randomness Processing Units (RPUs) for High-Performance Computation and Data SecurityQuside's Randomness Processing Unit (RPU) accelerates stochastic HPC and PQ cryptography by optimizing random workloads, enhancing efficiency and performance across various sectors. | EIC Accelerator | € 2.499.999 | 2024 | Details |
A new cardioprotective drug for acute treatment of myocardial infarction
ResoTher aims to validate RTP-026, an immunomodulating therapy, to reduce heart damage and HF risk post-myocardial infarction through Phase II clinical studies.
Clear, scalable and scientific framework to measure terrestrial biodiversity
3Bee leverages IoT, wildlife monitoring, and satellite data to measure and regenerate biodiversity, generating certified Biodiversity Credits for corporations to enhance ESG reporting and brand value.
Novel and Scalable microbial products for REgenerative agriculture
N-Spire aims to revolutionize agriculture by creating a sustainable bioactive fertilizer through innovative manufacturing techniques, enhancing soil health and reducing chemical dependency.
Quantum-based Randomness Processing Units (RPUs) for High-Performance Computation and Data Security
Quside's Randomness Processing Unit (RPU) accelerates stochastic HPC and PQ cryptography by optimizing random workloads, enhancing efficiency and performance across various sectors.
Vergelijkbare projecten uit andere regelingen
| Project | Regeling | Bedrag | Jaar | Actie |
|---|---|---|---|---|
How has the rapid scale up of malaria control in Africa impacted vector competence?This project aims to investigate the effects of insecticide use and drug resistance on malaria parasite development in mosquitoes to enhance vector control strategies and improve intervention options. | ERC STG | € 1.499.581 | 2023 | Details |
Mosquito-virus matchmaking: Elucidating the biological basis of compatibility between viruses and mosquitoesThis project aims to utilize single-cell technology and gene editing to understand and manipulate the compatibility between viruses and mosquito vectors, enhancing disease control strategies. | ERC STG | € 1.500.000 | 2023 | Details |
The malaria chemical atlas: Revealing the parasite-host functional interactomeThe MalChemAtlas project aims to uncover the chemical communication of the malaria parasite Plasmodium falciparum to develop novel interventions against malaria. | ERC COG | € 2.000.000 | 2023 | Details |
Mobile Bio-Lab to support first response in Arbovirus outbreaksMOBVEC aims to develop the first VBD Mobile Bio-Lab to provide real-time vector surveillance and disease modeling, enhancing outbreak response and saving lives and healthcare costs. | EIC Pathfinder | € 2.998.500 | 2023 | Details |
How has the rapid scale up of malaria control in Africa impacted vector competence?
This project aims to investigate the effects of insecticide use and drug resistance on malaria parasite development in mosquitoes to enhance vector control strategies and improve intervention options.
Mosquito-virus matchmaking: Elucidating the biological basis of compatibility between viruses and mosquitoes
This project aims to utilize single-cell technology and gene editing to understand and manipulate the compatibility between viruses and mosquito vectors, enhancing disease control strategies.
The malaria chemical atlas: Revealing the parasite-host functional interactome
The MalChemAtlas project aims to uncover the chemical communication of the malaria parasite Plasmodium falciparum to develop novel interventions against malaria.
Mobile Bio-Lab to support first response in Arbovirus outbreaks
MOBVEC aims to develop the first VBD Mobile Bio-Lab to provide real-time vector surveillance and disease modeling, enhancing outbreak response and saving lives and healthcare costs.